Product Usage:
THIS PRODUCT IS INTENDED FOR RESEARCH PURPOSES ONLY.
All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
FOX04-DRI
$300.00
- •Selectively eliminates senescent "zombie" cells
- •Disrupts p53-FOXO4 survival interaction
- •Leaves healthy cells completely unaffected
- •Reduces inflammatory SASP secretion
- •Restored function in aged mice (Cell, 2017)
- •Most specific senolytic compound available
Purchase Option
Recommended add-on
Reconstitution Solution — for Laboratory Use
Reconstitution Solution
30 mL — For Laboratory Use
$25.00
FOXO4-DRI is a D-retro-inverso peptide that selectively disrupts the p53-FOXO4 interaction. This blockade induces targeted apoptosis in senescent cells by altering specific transcriptional survival pathways.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
Certificate of Analysis
99%+
Purity
Passed full QC panel
- Purity (HPLC)
- Identity (HPLC / MS)
- Net Peptide Content
- Heavy Metals (ICP-MS)
- Sterility
- Endotoxin (USP <85>)
- Appearance
ISO/IEC 17025 Accredited
Compound Information
Technical specifications
Molecular Profile
What Is FOX04-DRI?
FOXO4-DRI is a D-retro-inverso peptide that selectively disrupts the p53-FOXO4 interaction. This blockade induces targeted apoptosis in senescent cells by altering specific transcriptional survival pathways.
Storage Requirements
Stability Information
Lyophilized (powder)
-20°C · up to 2 years
Reconstituted
-20°C · up to 30 days
